Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID-19 (CAMELOT)

ClinicalTrials.gov ID: NCT04583592

Public ClinicalTrials.gov record NCT04583592. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 6:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy of Camostat Mesilate for Treatment of COVID-19 in Outpatients

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, double-blind, placebo-controlled study of camostat mesilate in ambulatory patients with confirmed COVID-19 with at least one risk factor for severe illness.

Study identification

NCT ID
NCT04583592
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sagent Pharmaceuticals Inc.
Industry
Enrollment
295 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 9, 2020 (Actual)
Primary completion
Mar 31, 2021 (Actual)
Completion
Mar 31, 2021 (Actual)
Last update posted
Jan 18, 2022

2020 – 2021

United States locations

U.S. sites
21
U.S. states
10
U.S. cities
19
Facility City State ZIP Site status
Palmtree Clinical Research, Inc. (Site 125) Palm Springs California 92262 —
Synergy Healthcare, LLC (Site 124) Bradenton Florida 34208 —
Clinical Research of Brandon, LLC (Site 123) Brandon Florida 33511 —
Reliable Clinical Research, LLC (Site 100) Hialeah Florida 33012 —
A+ Research (Site 112) Miami Florida 33144 —
NextPhase Research Alliance at CANO HEALTH (Site 107) Miami Florida 33144 —
Ezy Medical Research (Site 106) Miami Florida 33175 —
Eminat LLC (Site 117) Plantation Florida 33317 —
Invictus Clinical Research Group, LLC (Site 101) Pompano Beach Florida 33064 —
Visionaries Clinical Research, LLC (Site 121) Atlanta Georgia 30318 —
Family Care Research (Site 114) Boise Idaho 83704 —
Cedar Crosse Research Center (Site 122) Chicago Illinois 60607 —
Massachusetts General Hospital (Site 110) Boston Massachusetts 02114 —
Oakland Medical Research Center (Site 108) Troy Michigan 48085 —
Cary Research Group (Site 111) Cary North Carolina 27518 —
Onsite Solutions (Site 118) Charlotte North Carolina 28208 —
STAT Research (Site 109) Springboro Ohio 45066 —
Toledo Institute of Clinical Research, Inc.(Site 105) Toledo Ohio 43617 —
Advanced Medical Trials (Site 104) Georgetown Texas 78628 —
Next Innovative Clinical Research (Site 115) Houston Texas 77021 —
Rio Grand Valley Clinical Research Institute (Site 120) Pharr Texas 78577 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04583592, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 18, 2022 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04583592 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →